PTJ
LLY icon

Paul Tudor Jones’s Eli Lilly LLY Stock Holding History

Paul Tudor Jones’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5M Buy
43,800
+40,500
+1,227% +$41.4M 0.07% 198
2026
Q1 		$3.04M Sell
3,300
-68,100
-95% -$69M 0.01% 1538
2025
Q4 		$76.7M Sell
71,400
-42,900
-38% -$41M 0.14% 98
2025
Q3 		$87.2M Buy
114,300
+81,200
+245% +$60.4M 0.15% 87
2025
Q2 		$25.8M Buy
33,100
+19,200
+138% +$14.9M 0.06% 267
2025
Q1 		$11.5M Sell
13,900
-29,400
-68% -$24.5M 0.04% 407
2024
Q4 		$33.4M Sell
43,300
-2,000
-4% -$1.66M 0.13% 75
2024
Q3 		$40.1M Buy
45,300
+8,900
+24% +$8M 0.15% 58
2024
Q2 		$33M Sell
36,400
-41,100
-53% -$32.9M 0.17% 79
2024
Q1 		$60.3M Buy
77,500
+39,700
+105% +$28.3M 0.38% 11
2023
Q4 		$22M Sell
37,800
-6,400
-14% -$3.74M 0.18% 102
2023
Q3 		$23.7M Buy
44,200
+32,700
+284% +$16.9M 0.24% 51
2023
Q2 		$5.39M Buy
11,500
+5,100
+80% +$2.14M 0.06% 393
2023
Q1 		$2.2M Buy
+6,400
New +$2.16M 0.03% 735

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paul Tudor Jones's LLY Position: Q2 2026 in Review

Paul Tudor Jones reduced its Eli Lilly (LLY) stake by 75% in Q2 2026, selling an estimated $95.8M and leaving 30,885 shares worth $37M. The position accounts for 0.05% of the portfolio, ranked #275.

Paul Tudor Jones first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. The position peaked at $115M in Q1 2026. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Paul Tudor Jones held 30,885 shares of Eli Lilly worth $37M as of Q2 2026.
  • Paul Tudor Jones sold 93,787 Eli Lilly shares in Q2 2026, an estimated $95.8M.
  • Eli Lilly made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #275 holding.
  • Paul Tudor Jones first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
  • Paul Tudor Jones's Eli Lilly position peaked at $115M in Q1 2026.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.